Sonova Holding AG (SONVY)
64.22
-1.26
(-1.92%)
USD |
OTCM |
May 17, 15:59
Sonova Total Assets (Quarterly): 6.419B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.419B |
| September 30, 2023 | 5.888B |
| September 30, 2023 | 5.888B |
| March 31, 2023 | 6.078B |
| September 30, 2022 | 5.330B |
| September 30, 2022 | 5.330B |
| March 31, 2022 | 6.053B |
| September 30, 2021 | 6.141B |
| September 30, 2021 | 6.141B |
| March 31, 2021 | 6.291B |
| September 30, 2020 | 5.931B |
| September 30, 2020 | 5.931B |
| March 31, 2020 | 4.673B |
| September 30, 2019 | 4.551B |
| September 30, 2019 | 4.551B |
| March 31, 2019 | 4.311B |
| September 30, 2018 | 4.315B |
| September 30, 2018 | 4.315B |
| March 31, 2018 | 4.512B |
| September 30, 2017 | 4.162B |
| September 30, 2017 | 4.162B |
| Date | Value |
|---|---|
| March 31, 2017 | 3.934B |
| September 30, 2016 | 3.862B |
| September 30, 2016 | 3.862B |
| March 31, 2016 | 2.851B |
| September 30, 2015 | 2.691B |
| September 30, 2015 | 2.691B |
| March 31, 2015 | 2.782B |
| September 30, 2014 | 2.758B |
| September 30, 2014 | 2.758B |
| March 31, 2014 | 2.924B |
| September 30, 2013 | 2.902B |
| September 30, 2013 | 2.902B |
| March 31, 2013 | 2.822B |
| September 30, 2012 | 2.536B |
| September 30, 2012 | 2.536B |
| March 31, 2012 | 2.524B |
| September 30, 2011 | 2.318B |
| March 31, 2011 | 2.363B |
| September 30, 2010 | 2.350B |
| March 31, 2010 | 2.206B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.551B
Minimum
Sep 2019
6.419B
Maximum
Mar 2024
5.680B
Average
5.931B
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 185.40M |
| CRISPR Therapeutics AG | 2.439B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 2.270M |
| Molecular Partners AG | 236.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.658B |
| Shareholders Equity (Quarterly) | 2.738B |
| Debt to Equity Ratio | 0.6135 |
| Current Ratio | 1.452 |
| Net Debt Paydown Yield | -3.24% |